LFVN as of Nov 2 · 00:12 ET
LFVNNasdaqPharmaceutical Preparations

Lifevantage Corp · Brief

Next report

1 day

Nov 3 · after closeest.Q1 FY27

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±26.7%
avg realized
±9.1%
Oct 29 '24±21.8%▼−0.39%×0.02
Feb 5 '25±31.6%▼−16.49%×0.52
May 6 '25±32.4%▼−6.60%×0.20
Sep 4 '25±32.7%▼−10.03%×0.31
Nov 4 '25±23.6%▲+4.43%×0.19
Q2 FY26±21.3%▼−16.76%×0.79
Q3 FY26±24.5%▼−16.33%×0.67
Q4 FY26±25.2%▼−1.47%×0.06
quarterimplied−35%0+35%realized×
Q4 FY26±25.2%▼−1.47%×0.06
Q3 FY26±24.5%▼−16.33%×0.67
Q2 FY26±21.3%▼−16.76%×0.79
Nov '25±23.6%▲+4.43%×0.19
Sep '25±32.7%▼−10.03%×0.31
May '25±32.4%▼−6.60%×0.20
2 older reports
Feb '25±31.6%▼−16.49%×0.52
Oct '24±21.8%▼−0.39%×0.02
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull1

87managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

14managers whose positions together comprise most of the reported value13F · Jun 30 '26
13 of 20largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

LFVN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±22.9% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.